Reminder of Part D Transition Policy and Expectations for the Upcoming Contract Year

Please see the attached memo from Cynthia G. Tudor, Ph.D., Director, Medicare Drug Benefit Group, regarding CMS' transition policy and our expectations for the upcoming contract year. Thank you.